fulvestrant has been researched along with 3,3',4,5'-tetrahydroxystilbene in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Macpherson, L; Matthews, J | 1 |
1 other study(ies) available for fulvestrant and 3,3',4,5'-tetrahydroxystilbene
Article | Year |
---|---|
Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; Aryl Hydrocarbon Receptor Nuclear Translocator; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1B1; Dose-Response Relationship, Drug; Estradiol; Estrogen Receptor alpha; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Kaempferols; Polychlorinated Dibenzodioxins; Receptors, Aryl Hydrocarbon; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Stilbenes; Teratogens; Transcription, Genetic | 2010 |